Connect Biopharma Holdings Limited (CNTB) vs Heron Therapeutics, Inc. (HRTX)
A side-by-side comparison of Connect Biopharma Holdings Limited and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.94HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — CNTB vs HRTX
growth of $100 · dividends reinvested · last 6yCNTB -95.1% (-39.6%/yr)HRTX -97.6% (-46.4%/yr)CNTB compounded faster over this window
CNTB HRTX
CNTB vs HRTX: by the numbers
- •HRTX is the larger company ($63M vs $59M market cap).
- •Both run net losses; HRTX's is the smaller (-22.52% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | HRTX |
|---|---|---|
| P/S ratio | N/A | 0.42 |
| P/B ratio | 2.20 | 10.82 |
Profitability
| Metric | CNTB | HRTX |
|---|---|---|
| Gross margin | 100.00% | 70.07% |
| Operating margin | -90740.62% | -7.19% |
| Net margin | -86687.50% | -22.52% |
| ROE | -132.16% | -492.89% |
| ROIC | -136.77% | -6.79% |
Growth (annualized)
| Metric | CNTB | HRTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.73% |
| Total return CAGR (5Y) | -47.22% | -48.61% |
Frequently asked
- How have CNTB and HRTX total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and HRTX delivered -48.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.